Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.

Journal: Neurology and therapy

Publication Year: 

Authors & Co-authors:  Barbanti Egeo Proietti d'Onofrio Aurilia Finocchi Di Clemente Zucco Doretti Messina